UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity

Bioorganic & medicinal chemistry, 2021-07, Vol.42, p.116266-116266, Article 116266

2021

Volltextzugriff (PDF)

Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss

Bioorganic & medicinal chemistry, 2023-01, Vol.78, p.117133, Article 117133

2023

Volltextzugriff (PDF)

Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy

Bioorganic & medicinal chemistry, 2017-08, Vol.25 (15), p.4100-4109

2017

Volltextzugriff (PDF)

VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents

Bioorganic & medicinal chemistry, 2020-03, Vol.28 (5), p.115328, Article 115328

2020

Volltextzugriff (PDF)

Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents

Bioorganic & medicinal chemistry, 2010-05, Vol.18 (10), p.3543-3550

2010

Volltextzugriff (PDF)

Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors

Bioorganic & medicinal chemistry, 2023-01, Vol.78, p.117152, Article 117152

2023

Volltextzugriff (PDF)

Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action

Bioorganic & medicinal chemistry, 2017-02, Vol.25 (3), p.1066-1075

2017

Volltextzugriff (PDF)

Design and synthesis of novel (S)-Naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models

Bioorganic & medicinal chemistry, 2021-05, Vol.37, p.116097-116097, Article 116097

2021

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of indoline-maleimide conjugates as potential antitumor agents for the treatment of colorectal cancer

Bioorganic & medicinal chemistry, 2024-06, Vol.108, p.117786, Article 117786

2024

Volltextzugriff (PDF)

Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential

Bioorganic & medicinal chemistry, 2021-11, Vol.50, p.116453, Article 116453

2021

Volltextzugriff (PDF)

Triptonide induces apoptosis and inhibits the proliferation of ovarian cancer cells by activating the p38/p53 pathway and autophagy

Bioorganic & medicinal chemistry, 2024-08, Vol.110, p.117788, Article 117788

2024

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of 4,6-diarylquinoxaline-based KDM4D inhibitors

Bioorganic & medicinal chemistry, 2024-11, Vol.114, p.117945, Article 117945

2024

Volltextzugriff (PDF)

Novel naphthoquinone-1H-1,2,3-triazole hybrids: Design, synthesis and evaluation as inductors of ROS-mediated apoptosis in the MCF-7 cells

Bioorganic & medicinal chemistry, 2024-03, Vol.102, p.117671-117671, Article 117671

2024

Volltextzugriff (PDF)

Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones

Bioorganic & medicinal chemistry, 2022-04, Vol.60, p.116626-116626, Article 116626

2022

Volltextzugriff (PDF)

Novel inhibitors of bromodomain and extra-terminal domain trigger cell death in breast cancer cell lines

Bioorganic & medicinal chemistry, 2024-10, Vol.112, p.117884, Article 117884

2024

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K/HDAC dual inhibitors

Bioorganic & medicinal chemistry, 2022-11, Vol.74, p.117067-117067, Article 117067

2022

Volltextzugriff (PDF)

Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates

Bioorganic & medicinal chemistry, 2024-05, Vol.105, p.117726-117726, Article 117726

2024

Volltextzugriff (PDF)

Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies

Bioorganic & medicinal chemistry, 2021-09, Vol.46, p.116384-116384, Article 116384

2021

Volltextzugriff (PDF)

Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma

Bioorganic & medicinal chemistry, 2024-09, Vol.111, p.117843, Article 117843

2024

Volltextzugriff (PDF)

Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy

Bioorganic & medicinal chemistry, 2021-10, Vol.47, p.116358-116358, Article 116358

2021

Volltextzugriff (PDF)

Design, synthesis, and biological evaluation of 2-(naphthalen-1-yloxy)-N-phenylacetamide derivatives as TRPM4 inhibitors for the treatment of prostate cancer

Bioorganic & medicinal chemistry, 2024-01, Vol.98, p.117584-117584, Article 117584

2024

Volltextzugriff (PDF)

Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents

Bioorganic & medicinal chemistry, 2023-03, Vol.82, p.117234-117234, Article 117234

2023

Volltextzugriff (PDF)

Novel gold-based complex GC7 suppresses cancer cell proliferation via impacting energy metabolism mediated by mitochondria

Bioorganic & medicinal chemistry, 2024-10, Vol.112, p.117897, Article 117897

2024

Volltextzugriff (PDF)

Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[h]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer

Bioorganic & medicinal chemistry, 2024-11, Vol.114, p.117944, Article 117944

2024

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents

Bioorganic & medicinal chemistry, 2014-04, Vol.22 (7), p.2060-2079

2014

Volltextzugriff (PDF)

1 – 25 von 655

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

ThemaOncology

ThemaPharmacology. Drug Treatments

Zeitschrift / SerieBioorganic & Medicinal Chemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(655)
Mit Volltextzugriff
(655)

Publikationsform

Artikel
(655)

Sprache

Englisch
(655)

Erscheinungsjahr

n.n

Thema

Drug Screening Assays, Antitumor
(647)
Humans
(632)
Chemistry
(612)
Chemistry, Medicinal
(610)
Chemistry, Organic
(610)
Life Sciences & Biomedicine
(610)
Pharmacology & Pharmacy
(610)
Physical Sciences
(610)
Science & Technology
(610)
Biochemistry & Molecular Biology
(604)
Structure-Activity Relationship
(508)
Antineoplastic Agents - Pharmacology
(487)
Antineoplastic Agents - Chemistry
(441)
Antineoplastic Agents - Chemical Synthesis
(427)
Cell Proliferation - Drug Effects
(421)
Cell Line, Tumor
(394)
Molecular Structure
(377)
Dose-Response Relationship, Drug
(343)
Animals
(177)
Drug Design
(160)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(655)
MEDLINE
(655)
IngentaConnect
(655)
Elsevier ScienceDirect Journals Complete
(655)
IngentaConnect Journals
(2)

Zeitschrift / Serie

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity

Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss

Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy

VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents

Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents

Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors

Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action

Design and synthesis of novel (S)-Naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models

Design, synthesis and biological evaluation of indoline-maleimide conjugates as potential antitumor agents for the treatment of colorectal cancer

Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential

Triptonide induces apoptosis and inhibits the proliferation of ovarian cancer cells by activating the p38/p53 pathway and autophagy

Design, synthesis and biological evaluation of 4,6-diarylquinoxaline-based KDM4D inhibitors

Novel naphthoquinone-1H-1,2,3-triazole hybrids: Design, synthesis and evaluation as inductors of ROS-mediated apoptosis in the MCF-7 cells

Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones

Novel inhibitors of bromodomain and extra-terminal domain trigger cell death in breast cancer cell lines

Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K/HDAC dual inhibitors

Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates

Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies

Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma

Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy

Design, synthesis, and biological evaluation of 2-(naphthalen-1-yloxy)-N-phenylacetamide derivatives as TRPM4 inhibitors for the treatment of prostate cancer

Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents

Novel gold-based complex GC7 suppresses cancer cell proliferation via impacting energy metabolism mediated by mitochondria

Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[h]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer

Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents

Aktive Filter

Suchergebnisse filtern